New to sedation?

There is a SAAD training scheme for you!

SAAD provides sedation training schemes for:

‘Standards for Conscious Sedation in the Provision of Dental Care’ (April 2015, 2020)

Following publication of the IACSD standards in April 2015, dentists, doctors, dental hygienists/therapists and dental nurses who have no previous experience in conscious sedation for dentistry must now undertake appropriate training before commencing independent clinical practice.

All training programmes for ‘new starters’ must include supervised clinical experience and have external validation. UK university-based courses and those run by Postgraduate Deaneries are deemed to be compliant. Other courses leading to independent (i.e. unsupervised) practice, including those run by private providers, must be accredited by the Sedation Training and Accreditation Committee (STAC) of IACSD.

The IACSD Standards state that practitioners offering supervised clinical experience in conscious sedation must now be accredited by a university, deanery or IACSD (p34, 86).

Remimazolam for intravenous conscious sedation for dental procedures

SAAD & DSTG position statement on clinical use and training

13 September 2022

Remimazolam (Byfavo, Paion) received UK market authorisation for intravenous procedural sedation in 2021 and is now available from suppliers. Webinars and conference speakers are presenting information about the use of Remimazolam in dentistry and SAAD/DSTG are being asked by their members for advice about the training required and the appropriate use for dental sedation.

The Intercollegiate Advisory Committee for Sedation in Dentistry (IACSD) set the current standards for clinical use and training for dentists and doctors providing sedation for dentistry in the UK. The current document pre-dates Remimazolam authorisation and does not cover the use and training required.

SAAD and DSTG have written to IACSD to ask for clarification on the use of Remimazolam specifically if further clinical supervision and logbook cases will be required for clinicians trained in the use of intravenous midazolam. SAAD recommends that members await further clarification before introducing remimazolam into their clinical practice.

References:

Byfavo 20 mg powder for solution for injection. Accessed online 06/09/2022 https://www.medicines.org.uk/emc/product/12746/smpc

IACSD (v1.1, 2020) Standards for Conscious Sedation in the Provision of Dental Care. Intercollegiate Advisory Committee for Sedation in Dentistry